Evidence map›Paper›PMID 30467638›Full record

ReviewHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2019

Hypertension Management at Older Age: An Update.

Rita Del Pinto, Claudio Ferri

Abstract readReview
PubMed Publisher
In one paragraph

Review in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Twelve Smartphone Applications for Health Management of Older Adults during the COVID-19 Pandemic.International journal of environmental research and public health · 2021
    Article
  8. Article
  9. Hypertension Management and Control in Italy: A Real-World Survey in Elderly Patients.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021
    Article
  10. Review
  11. Article
  12. Tooth Loss and Blood Pressure in Parkinson's Disease Patients: An Exploratory Study on NHANES Data.International journal of environmental research and public health · 2021
    Article
  13. Article
  14. Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies.Advances in pharmacological and pharmaceutical sciences · 2021
    Review
  15. The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020
    Review
  16. Article
  17. Periodontitis and Hypertension: Is the Association Causal?High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020
    Review
  18. Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020
    Review
  19. Article
  20. DNA NAging · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rita Del PintoDepartment of Life, Health and Environmental Sciences, University of L'Aquila, San Salvatore Hospital, Delta 6 building, 67100, L'Aquila, Italy. ritadelpinto@gmail.com.ORCID http://orcid.org/0000-0003-4058-0655
Claudio FerriDepartment of Life, Health and Environmental Sciences, University of L'Aquila, San Salvatore Hospital, Delta 6 building, 67100, L'Aquila, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a risk factor for cardiovascular morbidity and mortality with increasing prevalence with age, whose treatment is associated with benefits over fatal and non-fatal cardiovascular events even later in life. However, there are persistent concerns on the short- and long-term weighted benefits of treating hypertension in the very old, particularly in those with specific clinical features. In fact, a broad range of clinical scenarios can be observed at older ages, spanning from the healthy to the frailest patient, and hypertension clinical trials have traditionally excluded the latter, thus preventing the unconditioned application to these patients of the same recommendations as in younger ages. Persistent issues regarding high blood pressure management in the very old adult are mainly related to treatment threshold and targets, which have been differently addressed by American and European guidelines. Herein, we will examine the challenges related to high blood pressure treatment in healthy and frail older and very old adults. We will discuss the evidence behind current recommendations. Finally, we will recapitulate the recommended treatment options for high blood pressure in these patients in the light of the most recent guidelines.

Indexed as

AgingAgedAged, 80 and overAge FactorsAntihypertensive AgentsBlood PressureComorbidityEvidence-Based MedicineFrail ElderlyFrailtyGeriatric AssessmentHumansHypertensionMiddle AgedPractice Guidelines as TopicRisk FactorsAntihypertensive AgentsAgingAntihypertensive agentsCardiovascular diseasesCerebrovascular diseasesFrailtyHypertension

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.